PURPOSE: To establish the protective efficacy against late complications of electron therapy using customized lead eye shields in cases with orbital and periorbital lesions. METHODS: Between 1982 and 2006, 16 patients with 22 orbital and periorbital lesions were treated by electron therapy. Customized lead eye shields were prepared and placed in the respective patients' eyes during each fraction of electron therapy. The toxicity and local control rates were analyzed. RESULTS: The preparation period for the customized lead eye shields was 2 days. The shields could be used throughout the treatment period in all the patients. No evidence of radiation cataract was observed in 15 of the 16 patients. None of the patients developed corneal ulceration or evidence of lead poisoning. CONCLUSION: Customized lead eye shields could be made relatively quickly, and electron therapy for orbital and periorbital lesions could be undertaken safely without any late complication. 2008 S. Karger AG, Basel.
PURPOSE: To establish the protective efficacy against late complications of electron therapy using customized lead eye shields in cases with orbital and periorbital lesions. METHODS: Between 1982 and 2006, 16 patients with 22 orbital and periorbital lesions were treated by electron therapy. Customized lead eye shields were prepared and placed in the respective patients' eyes during each fraction of electron therapy. The toxicity and local control rates were analyzed. RESULTS: The preparation period for the customized lead eye shields was 2 days. The shields could be used throughout the treatment period in all the patients. No evidence of radiation cataract was observed in 15 of the 16 patients. None of the patients developed corneal ulceration or evidence of lead poisoning. CONCLUSION: Customized lead eye shields could be made relatively quickly, and electron therapy for orbital and periorbital lesions could be undertaken safely without any late complication. 2008 S. Karger AG, Basel.
Authors: J G Letschert; D González González; J Oskam; L Koornneef; J D van Dijk; R Boukes; J Bras; P van Heerde; H Bartelink Journal: Radiother Oncol Date: 1991-09 Impact factor: 6.280
Authors: K J Minehan; J A Martenson; J A Garrity; P J Kurtin; P M Banks; M G Chen; J D Earle Journal: Int J Radiat Oncol Biol Phys Date: 1991-04 Impact factor: 7.038
Authors: Sudershan Bhatia; Arnold C Paulino; John M Buatti; Nina A Mayr; B-Chen Wen Journal: Int J Radiat Oncol Biol Phys Date: 2002-11-01 Impact factor: 7.038
Authors: P J Fitzpatrick; G A Thompson; W M Easterbrook; B L Gallie; D G Payne Journal: Int J Radiat Oncol Biol Phys Date: 1984-04 Impact factor: 7.038
Authors: M M Austin-Seymour; S S Donaldson; P R Egbert; I R McDougall; J P Kriss Journal: Int J Radiat Oncol Biol Phys Date: 1985-02 Impact factor: 7.038
Authors: Poonam Yadav; Kevin Kozak; Ranjini Tolakanahalli; V Ramasubramanian; Bhudatt R Paliwal; James S Welsh; Yi Rong Journal: Med Dosim Date: 2011-09-16 Impact factor: 1.482
Authors: Tal Eitan; Nicholas J Damico; Rajesh Pidikiti; Michael Z Kharouta; Donald Dobbins; Frederick B Jesseph; Mark Smith; Ankit Mangla; Theodoros N Teknos; David B Mansur; Mitchell Machtay; Min Yao; Aashish D Bhatt Journal: Int J Part Ther Date: 2019-12-16
Authors: Nicholas J Damico; Anna K Wu; Michael Z Kharouta; Tal Eitan; Rajesh Pidikiti; Frederick B Jesseph; Mark Smith; Christian Langmack; Diana L Mattson; Donald Dobbins; David B Mansur; Mitchell X Machtay; Jennifer A Dorth; Serah Choi; Min Yao; Aashish D Bhatt Journal: Int J Part Ther Date: 2021-03-26
Authors: J John Lucido; Andrew J Veres; Shawn M Kehret; John A Angeli; Robert D Highet; Robert L Foote; Scott C Lester; Chris L Deufel Journal: J Appl Clin Med Phys Date: 2022-07-11 Impact factor: 2.243